SPL not making an announcement either because it is too bad, or demand exceeding supply specially for India.
Nevertheless if was not a shareholder not in a million years i i would have heard of Viraleze.
Lab results not enough. We need a serious human trial. To be done w a big pharma like Merck or Mundi.
I hope Viraleze does not become another vivagel, a great product never heard of.
SPL Price at posting:
$1.70 Sentiment: Buy Disclosure: Held
